Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck to Hold Second-Quarter 2022 Sales and Earnings Conference Call July 28
06:45am, Wednesday, 29'th Jun 2022
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2022 sales and earnings conference call with institution
Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration
04:25pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
Sutro Biopharma (STRO) inks a partnership and licensing deal with Astellas Pharma to discover and develop iADCs for cancer patients not responding to existing therapies.
Investors Need Not Be Alarmed by Drug Patent Expirations
04:02pm, Tuesday, 28'th Jun 2022
Investors who are sweating the loss of patent protection for some of Big Pharma's top-selling drugs should relax.
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
02:41pm, Tuesday, 28'th Jun 2022 Zacks Investment Research
The EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to AstraZeneca's (AZN) cancer drugs, Enhertu and Lynparza, for treating certain patients with breast can
Why Call Traders Should Consider Merck Stock
10:20am, Tuesday, 28'th Jun 2022
Merck & Co., Inc.'s (NYSE:MRK) recent breakout above the $88 level took out both its 2021 and 2000 highs.
All-time highs for pharma stocks: Names to trade now
06:59pm, Monday, 27'th Jun 2022
Big pharma surges, and here are the names to trade. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Dan Nathan, Courtney Garcia and Karen Finerman.
Pfizer: 3 Trades To Buy Into Cash Rich Pharma Giant
02:28pm, Monday, 27'th Jun 2022 Investing.com
Company News for Jun 27, 2022
01:42pm, Monday, 27'th Jun 2022 Zacks Investment Research
Companies in The News Are: KMX,BZ,FDX,SGEN,MRK
Merck (MRK) Keytruda Gets Europe Nod for Expanded Melanoma Use
01:02pm, Monday, 27'th Jun 2022 Zacks Investment Research
European Commission approves Merck's (MRK) Keytruda as an adjuvant treatment for adults and adolescent patients with stage IIB or IIC melanoma and who have undergone complete resection.
Merck (MRK) Keytruda Gets Europe Nod for Expanded Melanoma Use
10:46am, Monday, 27'th Jun 2022
European Commission approves Merck's (MRK) Keytruda as an adjuvant treatment for adults and adolescent patients with stage IIB or IIC melanoma and who have undergone complete resection.
Still Think Tesla Is Expensive? This Stat Will Change Your Mind
10:01am, Monday, 27'th Jun 2022 The Motley Fool
When you factor in growth, the auto stock is actually very reasonably priced.
Seagen Would Be A Great Fit For Merck
09:57am, Sunday, 26'th Jun 2022
Seagen had two setbacks this year - the below-consensus FY2022 guidance and the resignation of CEO Siegall. The stock shot up this month when rumors surfaced that Merck is interested in acquiring the
3 Top Dividend Stocks for Generating Passive Income
09:57am, Sunday, 26'th Jun 2022 The Motley Fool
These stocks offer attractive dividends that investors should be able to count on.
4 Top Dividend Stocks To Watch Amid Recession Concerns
09:30am, Sunday, 26'th Jun 2022
Do these dividend stocks have a place in your portfolio right now?
3 Top Dividend Stocks for Generating Passive Income
05:57am, Sunday, 26'th Jun 2022
These stocks offer attractive dividends that investors should be able to count on.
